OpenEvidence, the startup behind an AI chatbot that helps physicians find and cite medical information, has considered raising about $200 million from investors who have offered a valuation of roughly $20 billion, according to a report by The Information. The potential deal would extend one of the steepest valuation climbs in AI healthcare, coming just months after the company's last financing.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.